Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Dr.Evidence is an advanced AI-driven platform for landscape intelligence that aims to enhance efficiency in clinical, regulatory, labeling, safety, market access, and medical affairs sectors, allowing life sciences companies to expedite product launches and sustain their market presence. By uniting teams from various locations, therapeutic fields, and departments around a centralized scientific knowledge base, the platform dismantles barriers, fosters teamwork, and enhances strategic decision-making. Leveraging augmented intelligence, which merges human skill with targeted AI solutions, Dr.Evidence provides rapid insights through efficient content summarization and interactive Q&A powered by generative AI technologies. Additionally, it boasts strong scientific search functions across a wide range of content types, employing more than 25 robust models in large language processing, machine learning, and natural language understanding. Users can swiftly evaluate multiple content sources to gain a comprehensive understanding of the landscape, ultimately leading to more informed and timely decisions in their respective fields. This comprehensive approach not only streamlines workflows but also significantly contributes to better outcomes in life sciences.

Description

MedAffairs AI is a cloud-based machine learning tool empowered by artificial intelligence, specifically crafted to optimize the Medical Affairs sector within the pharmaceutical industry. Leveraging an extensive repository of medical affairs information, it delivers quick and precise answers to inquiries, thereby minimizing the time users spend sifting through various drives and folders. This innovative platform facilitates the smooth incorporation of internal materials such as clinical trials, standard operating procedures, and articles, allowing users to easily obtain answers by querying their uploaded documents. Each answer provided is linked to the relevant source document, ensuring straightforward referencing. Furthermore, MedAffairs AI enables searches of both internal and external data, offering thorough insights into medical knowledge, regulatory compliance, engagement with key opinion leaders, as well as the formulation and planning of medical strategies. In this way, the tool not only saves time but also enhances the efficiency of the Medical Affairs team in their decision-making processes.

API Access

Has API No 

API Access

Has API No 

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial No 
Free Version No 

Pricing Details

No price information available.
Free Trial No 
Free Version No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Customer Support

Business Hours No 
Live Rep (24/7) Yes 
Online Support Yes 

Customer Support

Business Hours Yes 
Live Rep (24/7) No 
Online Support Yes 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) Yes 
In Person No 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) Yes 
In Person Yes 

Vendor Details

Company Name

Dr.Evidence

Country

United States

Website

www.drevidence.com/product/platform

Vendor Details

Company Name

Accreditation Council for Medical Affairs (ACMA)

Founded

2015

Country

United States

Website

medaffairsai.org

Product Features

Product Features

Alternatives

Alternatives

AIMedInfo Reviews

AIMedInfo

Accreditation Council for Medical Affairs (ACMA)
ACMA Engage Reviews

ACMA Engage

Accreditation Council for Medical Affairs (ACMA)
ANCORA Reviews

ANCORA

Amedea Pharma